NeurogesX

NeurogesX

Develops and commercializes therapies for chronic peripheral neuropathic pain.

Launch date
Employees
Market cap
-
Enterprise valuation
€4—5m (Dealroom.co estimates Mar 2012.)
San Carlos California (HQ)
Authorizing premium user...